Research output: Contribution to journal › Article › peer-review
Comparative Analysis of Carotid Artery Stenting and Carotid Endarterectomy in Clinical Practice. / Karpenko, Andrey; Starodubtsev, Vladimir; Ignatenko, Pavel et al.
In: Journal of Stroke and Cerebrovascular Diseases, Vol. 29, No. 5, 104751, 05.2020.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Comparative Analysis of Carotid Artery Stenting and Carotid Endarterectomy in Clinical Practice
AU - Karpenko, Andrey
AU - Starodubtsev, Vladimir
AU - Ignatenko, Pavel
AU - Dixon, Frances
AU - Bugurov, Savr
AU - Bochkov, Igor
AU - Rabtsun, Artem
AU - Gostev, Alexander
AU - Ruzankin, Pavel
AU - Brusaynskaya, Anna
N1 - Publisher Copyright: © 2020 Elsevier Inc. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/5
Y1 - 2020/5
N2 - The objective of the study was to describe immediate and long-term results of carotid endarterectomy (CEA) versus carotid stenting (CAS) with embolic protection in patients with severe carotid artery stenosis in clinical practice. Materials and Methods: This is a retrospective cohort study, conducted between 2009 and 2017. During the analyzed period, 2132 operations (2006 patients) were performed: 1215 (57%) CEA and 917 (43%) CAS. 278 patients (13.8% of 2006) were not contactable during the follow-up period (>30 days) leaving 1791 cases (1728 patients) for inclusion in the analysis. Propensity score matching was used to compare the treatment results of groups (561 cases were matched out of 1791). The results of 615 CEA (316 eversion, 299 “classic” with patch) and 615 CAS (using a variety of carotid stents) were compared. Results: In the asymptomatic subgroup (n = 455), the 30-day rate of stroke was not significantly different between the CEA group and the CAS group (1.5% versus 2.4%, P =.48). The 5-year rate of stroke was not significantly higher for CAS than for CEA (4.6% versus 3.3%, P =.3). In the symptomatic subgroup (n = 160), the 30-day rate of stroke was significantly higher in the CAS group than in the CEA group (7.5% versus 2.5%, P =.04). The 5-year rate of stroke was 13% for CAS and 8.7% for CEA (P =.2). Conclusions: In the symptomatic subgroup, the 30-day rate of stroke was significantly higher in the CAS group than in the CEA group, therefore the use of CAS for symptomatic patients in routine practice should be limited. Our study demonstrates that the rates of stroke and survival after CEA and CAS in patients aged 80 years or younger with asymptomatic or symptomatic severe carotid stenosis did not differ significantly over a period of 5 years.
AB - The objective of the study was to describe immediate and long-term results of carotid endarterectomy (CEA) versus carotid stenting (CAS) with embolic protection in patients with severe carotid artery stenosis in clinical practice. Materials and Methods: This is a retrospective cohort study, conducted between 2009 and 2017. During the analyzed period, 2132 operations (2006 patients) were performed: 1215 (57%) CEA and 917 (43%) CAS. 278 patients (13.8% of 2006) were not contactable during the follow-up period (>30 days) leaving 1791 cases (1728 patients) for inclusion in the analysis. Propensity score matching was used to compare the treatment results of groups (561 cases were matched out of 1791). The results of 615 CEA (316 eversion, 299 “classic” with patch) and 615 CAS (using a variety of carotid stents) were compared. Results: In the asymptomatic subgroup (n = 455), the 30-day rate of stroke was not significantly different between the CEA group and the CAS group (1.5% versus 2.4%, P =.48). The 5-year rate of stroke was not significantly higher for CAS than for CEA (4.6% versus 3.3%, P =.3). In the symptomatic subgroup (n = 160), the 30-day rate of stroke was significantly higher in the CAS group than in the CEA group (7.5% versus 2.5%, P =.04). The 5-year rate of stroke was 13% for CAS and 8.7% for CEA (P =.2). Conclusions: In the symptomatic subgroup, the 30-day rate of stroke was significantly higher in the CAS group than in the CEA group, therefore the use of CAS for symptomatic patients in routine practice should be limited. Our study demonstrates that the rates of stroke and survival after CEA and CAS in patients aged 80 years or younger with asymptomatic or symptomatic severe carotid stenosis did not differ significantly over a period of 5 years.
KW - Brachiocephalic arteries
KW - carotid artery
KW - carotid endarterectomy
KW - carotid stenting
KW - TRIAL
KW - STENOSIS
KW - ANGIOPLASTY
KW - RISK
KW - ISCHEMIC-STROKE
UR - http://www.scopus.com/inward/record.url?scp=85081197534&partnerID=8YFLogxK
U2 - 10.1016/j.jstrokecerebrovasdis.2020.104751
DO - 10.1016/j.jstrokecerebrovasdis.2020.104751
M3 - Article
C2 - 32160955
AN - SCOPUS:85081197534
VL - 29
JO - Journal of Stroke and Cerebrovascular Diseases
JF - Journal of Stroke and Cerebrovascular Diseases
SN - 1052-3057
IS - 5
M1 - 104751
ER -
ID: 23802029